Xiamen Jiukang Medical Instrument Co., Ltd – Trademark Portfolio

Entity Type: 99

Xiamen Jiukang Medical Instrument Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ELOWOKE. The owner is based in Xiamen, Fujian.

3A60, Bldg 8, Jiaheliangku Cultural Park

Xiamen, Fujian 361001 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ELOWOKE
ELOWOKE
Registered 2021

Trademark Classifications

Xiamen Jiukang Medical Instrument Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

Frequently Asked Questions

How many trademarks does Xiamen Jiukang Medical Instrument Co., Ltd have?

Xiamen Jiukang Medical Instrument Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xiamen Jiukang Medical Instrument Co., Ltd file in?

Xiamen Jiukang Medical Instrument Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 11 (Environmental Control). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are Xiamen Jiukang Medical Instrument Co., Ltd's most well-known trademarks?

Xiamen Jiukang Medical Instrument Co., Ltd's registered trademark portfolio includes well-known marks such as ELOWOKE. These are among 1 currently registered trademark in the portfolio.

What is Xiamen Jiukang Medical Instrument Co., Ltd's trademark registration success rate?

Xiamen Jiukang Medical Instrument Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.